Asian Spectator

Times Advertising

Cipla receives final approval for generic version of GlaxoSmit...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
MUMBAI, India, 02 March 2021 /PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087); (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Foo...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Bahaya bertanya ke AI: Separuh jawaban kesehatan menyesatkan, meski terdengar meyakinkan

Ilustrasi AI.Who is Danny/Shutterstock.comBayangkan kamu baru saja didiagnosis kanker stadium awal. Sebelum janji temu berikutnya dengan dokter, kamu bertanya ke chatbot berbasis kecerdasan buatan (AI...

Why Contractors Suction Hose Solutions Are Essential For Heavy-Duty Fluid Handling

In industries where materials move as relentlessly as time itself, equipment must match that intensity. Whether on construction sites, agricultural operations, or large-scale industrial setups, flui...

Skenario terburuk El Niño 2026: Puncak ‘neraka’ panas yang mengancam

Tahun ini Indonesia diprediksi bakal menghadapi musim kemarau yang tidak biasa. Bukan hanya sekadar panas, musim kemarau juga diperkirakan akan datang lebih cepat, lebih kering, dan masanya lebih lama...